June 9, 2026
GAINESVILLE, Fla. — New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher…
Department of Biochemistry and Molecular Biology, +3 more
November 22, 2022
Scientists at UF Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating…
UF Health, University of Florida
July 20, 2020
New preclinical research shows a commonly used Type 2 diabetes drug can improve symptoms in a specific genetic form of ALS and frontotemporal dementia in mice.…
Department of Molecular Genetics and Microbiology, Department of Neurology, Department of Pathology, Immunology, and Laboratory Medicine, +4 more
December 9, 2019
New preclinical research shows promise for a potential treatment pathway aimed at slowing the disease process and extending survival in patients with ALS,…
Department of Molecular Genetics and Microbiology, Department of Neurology, +3 more
March 18, 2019
Three renowned neuroscientists from top U.S. research institutions will join the newly established Norman Fixel Institute for Neurological Diseases at UF…
Department of Neurology, Department of Neuroscience, Department of Pathology, Immunology, and Laboratory Medicine, +5 more
October 19, 2017
In patients with myotonic dystrophy and related genetic diseases, abnormally long, repetitive DNA sequences lead to a host of problems in the muscle, heart and…
Department of Molecular Genetics and Microbiology, +3 more
